Millennium Management’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-21,888
| Closed | -$206 | – | 5833 |
|
|
2020
Q3 | $206 | Sell |
21,888
-3,737
| -15% | -$35.5K | ﹤0.01% | 4050 |
|
|
2020
Q2 | $196K | Buy |
+25,625
| New | +$196K | ﹤0.01% | 3853 |
|
|
2020
Q1 | – | Sell |
-491,713
| Closed | -$5.98M | – | 4814 |
|
|
2019
Q4 | $5.98M | Sell |
491,713
-310,894
| -39% | -$3.4M | 0.01% | 1778 |
|
|
2019
Q3 | $9.27M | Buy |
802,607
+705,600
| +727% | +$7.43M | 0.01% | 1328 |
|
|
2019
Q2 | $969K | Sell |
97,007
-331,858
| -77% | -$3.58M | ﹤0.01% | 2833 |
|
|
2019
Q1 | $5.52M | Buy |
428,865
+36,835
| +9% | +$549K | 0.01% | 1683 |
|
|
2018
Q4 | $5.96M | Sell |
392,030
-143,980
| -27% | -$2.74M | 0.01% | 1468 |
|
|
2018
Q3 | $10.7M | Buy |
536,010
+95,131
| +22% | +$2.17M | 0.01% | 1268 |
|
|
2018
Q2 | $8.6M | Sell |
440,879
-33,917
| -7% | -$750K | 0.01% | 1423 |
|
|
2018
Q1 | $9.57M | Sell |
474,796
-167,302
| -26% | -$2.83M | 0.01% | 1360 |
|
|
2017
Q4 | $8.51M | Sell |
642,098
-892,194
| -58% | -$13.5M | 0.01% | 1432 |
|
|
2017
Q3 | $28.3M | Buy |
1,534,292
+81,919
| +6% | +$1.53M | 0.04% | 597 |
|
|
2017
Q2 | $26.7M | Buy |
1,452,373
+1,152,551
| +384% | +$22.8M | 0.05% | 551 |
|
|
2017
Q1 | $6.76M | Buy |
299,822
+113,859
| +61% | +$2.73M | 0.01% | 1264 |
|
|
2016
Q4 | $6.47M | Sell |
185,963
-34,115
| -16% | -$1.02M | 0.01% | 1164 |
|
|
2016
Q3 | $5.39M | Buy |
+220,078
| New | +$5.5M | 0.01% | 1295 |
|
|
2016
Q2 | – | Sell |
-105,964
| Closed | -$2.43M | – | 3755 |
|
|
2016
Q1 | $2.48M | Sell |
105,964
-1,234,273
| -92% | -$29.3M | 0.01% | 1662 |
|
|
2015
Q4 | $40.5M | Buy |
1,340,237
+684,562
| +104% | +$22.1M | 0.09% | 305 |
|
|
2015
Q3 | $26.1M | Sell |
655,675
-440,963
| -40% | -$27.4M | 0.05% | 454 |
|
|
2015
Q2 | $75.7M | Buy |
1,096,638
+187,433
| +21% | +$11.8M | 0.14% | 148 |
|
|
2015
Q1 | $49.7M | Buy |
909,205
+155,819
| +21% | +$7.43M | 0.09% | 273 |
|
|
2014
Q4 | $32.1M | Sell |
753,386
-137,951
| -15% | -$4.98M | 0.07% | 387 |
|
|
2014
Q3 | $28.4M | Buy |
891,337
+236,837
| +36% | +$5.05M | 0.07% | 345 |
|
|
2014
Q2 | $13.6M | Sell |
654,500
-113,714
| -15% | -$2.1M | 0.04% | 668 |
|
|
2014
Q1 | $14.9M | Buy |
768,214
+619,287
| +416% | +$13.2M | 0.04% | 584 |
|
|
2013
Q4 | $3.62M | Buy |
148,927
+131,277
| +744% | +$3.09M | 0.01% | 1399 |
|
|
2013
Q3 | $379K | Sell |
17,650
-5,913
| -25% | -$140K | ﹤0.01% | 2731 |
|
|
2013
Q2 | $524K | Buy |
+23,563
| New | +$519K | ﹤0.01% | 2317 |
|
Millennium Management's AMAG Position: Q4 2020 in Review
Millennium Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 21,888 shares — an estimated $206 sold.
Millennium Management first reported a position in AMAG in Q2 2013 and held it in 28 quarters. The position peaked at $75.7M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Millennium Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Millennium Management sold 21,888 AMAG Pharmaceuticals shares in Q4 2020, an estimated $206.
- Millennium Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 28 quarters.
- Millennium Management's AMAG Pharmaceuticals position peaked at $75.7M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.